DOTmed March 4, 2024
Progenics Pharmaceuticals, a biopharmaceutical company, has accused radiology AI solution maker MIM Software of using its patented technology to secure an acquisition from GE HealthCare.
In documents filed in the U.S. District Court for the District of Massachusetts, Progenics said for years it discussed with MIM the possibility of integrating patents for new systems and methods to help physicians more consistently and accurately interpret CT and PET scans into MIM’s nuclear imaging software through a partnership.
It said it sent MIM a collaboration agreement in October 2022 but did not hear back for months, only to discover in June 2023 that MIM had published articles and information on its website about new features added to its Contour ProtégéAI and MIM...
Today's Sponsors
Today's Sponsor